The leader in know how and know why in oncology
We leverage provider and payer relationships, oncology experience and proprietary analytics to deliver actionable insights that drive successful market access.
Featured Insights
Article
Bispecific Antibodies: A Balancing Act of Promise and Complexity
Bispecific antibodies have emerged with great promise, but adoption has been slower than expected. This was a key topic discussed by a panel of 5 experts at the October 2024 Association for Value-Based Cancer Care (AVBCC) conference.
Read More
Podcast
Community Oncology Practice Economics - Podcast Part 2 of 3
In part 2 of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore the operational realities of oncology practice economics.
Lee Blansett
Podcast
Community Oncology Practice Economics - Podcast Part 1 of 3
In part 1 of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore the current state of oncology practice economics.
Lee Blansett
Article
Navigating the 340B Maze Amid the Inflation Reduction Act
As the Inflation Reduction Act (IRA) introduces new Maximum Fair Pricing (MFP) rules, integrated delivery networks (IDNs) and manufacturers will face the complexities of navigating overlapping 340B discounts and MFPs.
Emma Bijesse
The HMP Market Access Insights team helps us understand the interconnectivity between our major customer segments on really important issues and lead us toward better planning and business decisions.
Our Team
Lee Blansett
Executive Vice President
Cindy Chen
Head of Data Analytics
Chris Van Denburg
Director
